Wearable cardiac monitoring devices are small, body-worn sensors that continuously or intermittently track the electrical activity or blood flow patterns of your heart, then transmit that data for analysis. They range from clinical-grade adhesive chest patches prescribed by a cardiologist to consumer smartwatches you can buy off the shelf. The technology has changed rapidly in recent years, and the line between medical instrument and fitness gadget has blurred in ways that matter for how doctors diagnose heart conditions and how patients experience their own health data.
How They Actually Sense Your Heart
Almost every wearable cardiac monitor relies on one of two sensing methods, and understanding the difference matters because it shapes what the device can and cannot tell you.
The first is electrocardiography, or ECG. These devices detect the tiny electrical signals your heart generates with each beat. Clinical chest patches use electrodes pressed against your skin; smartwatches with ECG capability typically ask you to touch a metal contact with a fingertip to complete an electrical circuit through your body. The signal they capture is essentially a simplified version of the same tracing a hospital ECG machine produces, though with far fewer leads. In wearable ECG monitoring, signal quality depends heavily on how electrodes interface with the skin. Dry electrodes, common in patches, don’t require gel or any user preparation and generally avoid skin irritation, performing well during low-intensity activity. Materials like conductive silver fabric and stainless steel have been tested for motion resistance in these applications.
1PubMed Central. ECG signal quality in intermittent long-term dry electrode recordings with controlled motion artifactsThe second method is photoplethysmography, or PPG. This is the green light you see flashing on the back of most fitness trackers and smartwatches. PPG is an inexpensive optical technique that shines light into the skin and measures how much bounces back. Because blood absorbs light differently depending on volume, the sensor can detect the pulse of blood with each heartbeat.
2PubMed Central. A review on wearable photoplethysmography sensors and their potential future applications in health careThe critical distinction between the two is what they measure. ECG captures the heart’s electrical commands directly from the chest or through the body’s conduction pathways. PPG infers heart rhythm indirectly by watching blood volume changes in your wrist or fingertip. That indirect approach means PPG signals are influenced by factors like how compliant your blood vessels are, how long it takes the pulse wave to travel from your heart to your wrist, and what your microcirculation is doing at the moment.
3PubMed Central. A Comparative Study Between ECG- and PPG-Based Heart Rate Sensors for Heart Rate Variability Measurements: Influence of Body Position, Duration, Sex, and AgeThe Shift from Bulky to Barely Noticeable
For decades, if your doctor wanted to monitor your heart rhythm over time, the main options were the standard 12-lead ECG (a snapshot taken in the office), the Holter monitor (a brick-sized recorder connected to stick-on chest electrodes, worn for 24 to 48 hours), and event recorders (which you activate when you feel symptoms). These tools are useful, but each has practical drawbacks. Holter monitors are conspicuous under clothing, limit physical activity, and only capture a day or two of data. Event recorders depend on you being alert enough to press a button during a symptom.
Advances in miniaturization and wireless technology have produced adhesive patch monitors that sit directly on the chest, are nearly invisible under a shirt, and can record continuously for days or even weeks. These devices are unobtrusive and easy to use, which means people actually wear them for longer stretches, improving the odds of catching an irregular rhythm that only shows up sporadically.
4PubMed Central. Electrocardiographic patch devices and contemporary wireless cardiac monitoringOne newer patch-based monitor has received FDA clearance for 14-day continuous wear and has been tested for 30-day use without needing any electrode or battery replacement. In a feasibility study, the median wear time reached 29 continuous days with no clinically significant skin irritation.
5EP Europace. Feasibility and safety of a single patch-based device for 30 days of continuous, uninterrupted ambulatory ecg monitoringWhat Conditions Can They Catch
The headline clinical use for wearable cardiac monitors is detecting atrial fibrillation, the most common serious heart rhythm disorder. AF often comes and goes unpredictably, which makes it easy to miss during a brief office visit. A systematic review of wearable ECG devices found high sensitivity and specificity for detecting episodes of AF, though the results depend on algorithm quality, whether repeat measurements are taken, and the signal quality of the recording.
6PubMed Central. Diagnostic Accuracy of Wearable ECG Devices for Atrial Fibrillation and ST-Segment Changes: A Systematic ReviewDetection after stroke is a particularly high-stakes application. When someone has a stroke with no obvious cause, undiagnosed AF is a leading suspect because it can send blood clots to the brain. A meta-analysis of nearly a thousand patients monitored with external wearable devices after such strokes found AF in about one in five of them. Mobile cardiac telemetry, a form of continuous wearable monitoring, detected new AF in roughly one in ten patients.
7PubMed Central. Use of wearable technology in cardiac monitoring after cryptogenic stroke or embolic stroke of undetermined source: a systematic reviewBeyond AF, there are case reports of consumer smartwatches flagging other dangerous rhythms. In one documented series, a smartwatch helped identify ventricular tachycardia and a high burden of premature ventricular beats in a patient. Follow-up Holter monitoring confirmed the finding and ultimately led to a catheter ablation procedure to correct the problem.
8PubMed Central. Smartwatch detection of ventricular tachycardia: Case seriesPPG Versus ECG Smartwatches for Atrial Fibrillation
One question that comes up frequently is whether the optical PPG method in most smartwatches is good enough to catch AF, or whether ECG-capable watches are clearly better. The answer from the research is somewhat counterintuitive. A systematic review and meta-analysis comparing the two found that PPG-based smartwatches had a pooled sensitivity of about 97% and specificity of about 97% for AF detection, while ECG-based smartwatches showed a pooled sensitivity around 83% and specificity around 88%.
9PubMed Central. Comparison of diagnostic accuracy of electrocardiogram-based versus photoplethysmography-based smartwatches for atrial fibrillation detection: A Systematic Review and Meta-AnalysisThat gap may seem surprising, but it has a practical explanation. PPG sensors monitor continuously in the background without user action. ECG features on consumer watches typically require you to sit still and actively take a 30-second recording. Because AF is intermittent, the always-on nature of PPG improves the odds of catching an episode. A study comparing smartwatch PPG and ECG algorithms against long-term Holter recordings found that for AF episodes lasting longer than five minutes, the PPG algorithm achieved perfect sensitivity with about 84% specificity, while the ECG algorithm reached roughly 90% sensitivity and 67% specificity.
10PubMed Central. Continuous atrial fibrillation monitoring using a wearable smartwatch: Using long-term Holter as referenceThere is a significant catch, though. PPG is more vulnerable to noise. One study using continuous smartwatch PPG monitoring found that without a quality detection system filtering out garbage data, the device produced a false AF rate of about 48%, vastly overestimating the actual burden compared to a Holter monitor worn simultaneously.
11Circulation. Determining the Diagnostic Yield for Atrial Fibrillation Using Continuous Smartwatch MonitoringWhen the Watch Gets It Wrong
False alerts from smartwatches are not just a technical nuisance. They can affect how people feel about their own health. A study examining the impact of false AF alerts from smartwatches found that people who received them did not develop more clinical anxiety or changes in medication adherence. But they did report a meaningful decline in their sense of physical well-being and in their confidence managing their own symptoms. Those who received more than two false alerts experienced larger drops in both measures.
12PubMed Central. False Atrial Fibrillation Alerts from Smartwatches are Associated with Decreased Perceived Physical Well-being and Confidence in Chronic Symptoms ManagementThis is worth thinking about if you wear a smartwatch with heart monitoring features. A false alert does not mean something is wrong with your heart, but it can make you feel less healthy and less in control, even after a doctor confirms the alert was incorrect. The psychological cost is real and tends to grow with repeated false positives.
Skin Tone, Body Size, and Device Accuracy
PPG sensors rely on light penetrating the skin and bouncing back, which means anything that changes how skin interacts with light can affect accuracy. Melanin, the pigment responsible for skin color, absorbs the green light commonly used by wrist-worn sensors. A systematic review found that four out of ten studies reported significantly reduced heart rate accuracy in darker-skinned individuals compared to lighter-skinned participants.
13PubMed Central. Accuracy of Heart Rate Measurement with Wrist-Worn Wearable Devices in Various Skin Tones: a Systematic ReviewThe extent of the problem varies by brand and by what you’re doing. Some devices underestimated heart rate by 10 to 15 beats per minute in darker-skinned users during moderate to vigorous exercise, while showing minimal error in lighter-skinned participants. Other brands performed more consistently across skin tones, with less than 5 beats per minute of variation. During rest, errors tended to stay under 10% across all skin tones, but during cycling or resistance exercise, error rates exceeded 20% in individuals with higher pigmentation on some devices.
14PubMed Central. Photoplethysmography in Diverse Skin Tones: Evaluating Bias in Smartwatch Health MonitoringBody size also matters for adhesive patch monitors. In one study of 14-day ECG patches, higher body mass index independently predicted poorer compliance, primarily because the adhesive failed sooner on larger body types. Loss of adhesive was the main reason patches came off early, accounting for about 11% of compliance failures. People with higher weight and BMI were significantly more likely to experience the patch falling off prematurely.
15PubMed Central. Identifying Demographic Factors Affecting the ECG Duration Collected Using a Single‐Lead ECG Patch DeviceArtificial Intelligence Running on Your Wrist
Raw heart rhythm data from a wearable is not particularly useful until software interprets it. This is where artificial intelligence has become central to the field. Many consumer and clinical wearables now use machine learning algorithms to classify rhythms, flag abnormalities, and filter noise. A review of AI in wearable ECG monitoring found increasing use of deep learning approaches, particularly convolutional and recurrent neural networks that can handle the complexity of continuous biosignal data.
16PubMed Central. Electrocardiogram Monitoring Wearable Devices and Artificial-Intelligence-Enabled Diagnostic Capabilities: A ReviewIn practice, this means the algorithm is doing a lot of the clinical thinking that a technician or cardiologist once did manually when reviewing a Holter recording. The quality of that algorithm can make or break a device’s usefulness. Improved algorithms and repeat measurements have been shown to substantially boost the diagnostic accuracy of wearable ECG devices, but that same dependence on software underscores a current limitation: autonomous, reliable monitoring without any human review is not yet a solved problem.
6PubMed Central. Diagnostic Accuracy of Wearable ECG Devices for Atrial Fibrillation and ST-Segment Changes: A Systematic ReviewGetting Wearable Data to Your Doctor
Capturing heart rhythm data is only half the battle. The data also has to reach the people who can act on it. Integration into electronic health records remains a significant obstacle. Many wearable manufacturers use proprietary data formats and closed programming interfaces, which makes it difficult to feed information directly into a patient’s medical chart.
17European Heart Journal. Wearable devices and cardiovascular health: revolutionizing remote monitoring and disease preventionProgress is happening. Major electronic health record vendors now offer modules that allow wearable data to show up in patient charts or patient portals through platforms like Apple HealthKit and Google Fit. But the experience is inconsistent. Data might arrive in fragments, or in formats a clinician has to manually review outside their normal workflow, adding time rather than saving it.
17European Heart Journal. Wearable devices and cardiovascular health: revolutionizing remote monitoring and disease preventionReimbursement is another uneven landscape. In much of Europe, traditional Holter monitors and implantable loop recorders are universally reimbursed by health systems, but newer technologies like ECG patches and external recorders are often not. The reimbursement structures have not caught up with the technology, so coverage varies widely depending on where you live.
18European Heart Journal – Digital Health. Access and reimbursement of ambulatory cardiac monitoring across EuropePrivacy and Security of Heart Data
Wearable cardiac monitors produce a continuous stream of intimate health data, often transmitted wirelessly to cloud servers for processing. The rise of internet-connected medical devices has introduced serious security and privacy risks to personal health information.
19PubMed Central. Security Risks and User Perception towards Adopting Wearable Internet of Medical ThingsFor consumer smartwatches, data typically flows through the manufacturer’s cloud and is governed by the company’s privacy policy rather than the stricter medical-data regulations that apply to clinical devices. In the United States, the Health Insurance Portability and Accountability Act generally covers data handled by healthcare providers and insurers, but it does not automatically extend to Apple, Samsung, or Fitbit when you voluntarily share health data through their consumer apps. That distinction means your heart rhythm data may be subject to different rules depending on whether it was collected by your doctor’s prescribed patch or by your personal watch.
Cuffless Blood Pressure and Other Frontiers
AF detection is the most developed clinical application for wearable cardiac sensors, but the technology is being pushed toward other measurements. One of the most anticipated is cuffless blood pressure estimation. Pulse transit time, the interval between the heart’s electrical signal and the arrival of the corresponding pulse wave at a peripheral site like the wrist, has been the most commonly used technique for estimating blood pressure without an inflatable cuff.
20PubMed Central. Pulse transit time technique for cuffless unobtrusive blood pressure measurement: from theory to algorithmSome research prototypes combine accelerometers and optical sensors on a wristwatch to measure this transit time. One such device achieved root-mean-square errors of under 3 mmHg for diastolic pressure estimation after calibration, which would be clinically useful accuracy if it holds up at scale.
21PubMed Central. SeismoWatch: Wearable Cuffless Blood Pressure Monitoring Using Pulse Transit TimeNewer approaches have extended these models by adding supplemental indicators derived from PPG signal intensity, improving accuracy across different subject groups and over longer calibration intervals.
22Scientific Reports. Pulse Transit Time Based Continuous Cuffless Blood Pressure Estimation: A New Extension and A Comprehensive EvaluationIf cuffless blood pressure monitoring becomes reliable enough for everyday use, it could be transformative for managing hypertension, which typically requires periodic office visits with an arm cuff. A watch that tracked your blood pressure passively throughout the day would give both you and your doctor far more information to work with than a handful of office readings per year.
Children and Congenital Heart Disease
Most wearable cardiac devices are designed with adults in mind, but there is growing interest in using them for children and adults living with congenital heart disease. The American Heart Association published a science advisory noting that wearable biosensors enable continual, noninvasive monitoring at home for people with pediatric or congenital heart disease, allowing patients to access their own data and track their health over time. However, the advisory also pointed to significant remaining barriers: hardware designed for adult bodies does not always fit children well, data analysis pipelines are not calibrated for the different heart rate ranges and rhythm patterns seen in young patients, and clinical workflow integration remains incomplete for these higher-risk populations.
23PubMed. Advancing Wearable Biosensors for Congenital Heart Disease: Patient and Clinician Perspectives: A Science Advisory From the American Heart AssociationThis is an area where the promise of the technology substantially outpaces the reality. A child with a repaired congenital heart defect may need rhythm monitoring more than almost anyone, but the devices, algorithms, and care pathways have not been built with them in mind. It is one of the clearest gaps in the current ecosystem and one that several research groups are actively working to close.
Wearables Versus Implantable Monitors
For patients who have already had an unexplained stroke, the gold standard for long-term heart rhythm monitoring is an implantable loop recorder, a small device inserted under the skin of the chest that continuously monitors for years. Implantable recorders detect AF at higher rates than external wearables, with detection rates estimated around 15 to 25% compared to roughly 5 to 10% for wearable devices in this population.
24Cerebrovascular Diseases. Digital Health-Enabled Monitoring Strategies for Atrial Fibrillation Detection after Embolic Stroke of Undetermined Source: A Cost-Effectiveness Analysis of Implantable Loop Recorders, Wearable Devices, and Usual CareThat gap reflects the fundamental trade-off. An implantable recorder monitors every heartbeat, 24 hours a day, for up to three years, without any action from the patient and without being affected by skin contact, motion artifact, or battery life. Wearable devices, even the best adhesive patches, are limited by wear time, adhesive failure, and the patient’s willingness to keep wearing them. For high-risk patients where finding AF could change treatment, the implantable device finds more of what you are looking for. But it requires a minor surgical procedure, costs significantly more, and is not appropriate for broad screening of lower-risk populations, which is exactly where consumer wearables have their greatest potential role.